OpenVSafe by OpenVAERS
Search V-safe

H9C-79420-85659

2 vaccinations 2 coded responses 13 check-ins 2 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
770 / TX
Registered
2022-07-18
Relationship
Child or adolescent in my care
Guardian
9T5-31180-21133
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-18
    Registered in v-safe
  2. 2022-07-19
    Dose 1 — Pfizer-BioNTech
    Co-administered: Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus
  3. 2022-07-19
    Health check-in — day 0, dose 1, under 3
    Feeling: Fair · Site: Pain, Redness · Fever · Sleepiness, Irritability/crying, Loss of appetite
    Under 3 check-in
  4. 2022-07-21
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Site: Pain · Fever · Irritability/crying, Loss of appetite
    Under 3 check-in
  5. 2022-07-22
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Loss of appetite
    Under 3 check-in
  6. 2022-07-23
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-27
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-08-02
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-08-09
    Survey response — day 21, dose 1, under 3
    MedDRA: Upper respiratory tract infection — Feeling: Fair
    Free text: Upper respiratory infection, no fever
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-08-16
    Dose 2 — Pfizer-BioNTech
  11. 2022-08-23
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-09-01
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-09-06
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-09-13
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-09-23
    Survey response — day 35, dose 2, under 3
    MedDRA: Nasopharyngitis, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school
    Free text: Cold with congestion-covid negative
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-09-27
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-19Pfizer-BioNTech Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus
22022-08-16Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 21, dose 1, under 3

2022-08-09

Symptoms: Upper respiratory infection, no fever

Release 12 (Under 3) — day 35, dose 2, under 3

2022-09-23

Symptoms: Cold with congestion-covid negative

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test negative · · ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release